PART I . Overview Lisata Therapeutics, Inc. (together with its subsidiaries, the Company) is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other serious diseases. Our investigational product, certepetide (formerly known as LSTA1 or CEND-1), is designed to activate a novel uptake pathway (the C-end rule active transport mechanism) that allows co-administered or tethered (i.e., mo...
Q2 FY2026 — expected 2026-08-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0000320017-26-000023 | EDGAR | 80K words |
| 2025-02-27 | 2024-12-31 | 0000320017-25-000011 | EDGAR | — |
| 2024-02-29 | 2023-12-31 | 0000320017-24-000007 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0000320017-23-000011 | EDGAR | — |
| 2022-03-22 | 2021-12-31 | 0000320017-22-000016 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0000320017-21-000043 | EDGAR | — |
| 2020-03-05 | 2019-12-31 | 0000320017-20-000016 | EDGAR | — |
| 2019-03-14 | 2018-12-31 | 0000320017-19-000024 | EDGAR | — |
| 2018-03-22 | 2017-12-31 | 0000320017-18-000021 | EDGAR | — |
| 2017-03-17 | 2016-12-31 | 0000320017-17-000008 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0000320017-26-000038 | EDGAR | — |
| 2025-11-06 | 2025-09-30 | 0000320017-25-000070 | EDGAR | 21K words |
| 2025-08-07 | 2025-06-30 | 0000320017-25-000060 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0000320017-25-000030 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000320017-24-000058 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0000320017-24-000051 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000320017-24-000031 | EDGAR | — |
| 2023-11-02 | 2023-09-30 | 0000320017-23-000063 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0000320017-23-000055 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0000320017-23-000028 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000320017-22-000102 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0000320017-22-000057 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-04 | 0001140361-26-031028 | EDGAR | — |
| 2026-07-24 | 0001140361-26-029541 | EDGAR | — |
| 2026-07-17 | 0001140361-26-028763 | EDGAR | — |
| 2026-04-03 | 0001140361-26-013070 | EDGAR | 2K words |
| 2026-03-09 | 0000320017-26-000020 | EDGAR | — |
| 2026-02-27 | 0000320017-26-000012 | EDGAR | — |
| 2026-01-27 | 0000320017-26-000008 | EDGAR | — |
| 2026-01-21 | 0000320017-26-000006 | EDGAR | — |
| 2025-11-06 | 0000320017-25-000069 | EDGAR | — |
| 2025-10-14 | 0000320017-25-000066 | EDGAR | — |
344 total filings indexed. 312 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000320017 |
| Ticker | LSTA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.lisata.com |
| Listed | 1999-03-01 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/LSTA (~200 tokens, structured JSON with cryptographic provenance)